The Impact of Obesity on Cardiovascular Diseases: Heart Failure

Hatem Alansari1, Gina Lazzara1, Mohamad B Taha1

  • 1Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, US.

Insights

Obesity worsens heart function, but weight loss improves it. Paradoxically, obese heart failure patients may live longer, highlighting the need for targeted prevention and treatment strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Metabolic Disorders

Background:

  • Obesity and heart failure (HF) are prevalent global health issues.
  • Obesity negatively impacts cardiac structure and function, causing ventricular dysfunction.

Purpose of the Study:

  • To explore the complex relationship between obesity and heart failure.
  • To review pathophysiological mechanisms, the obesity paradox, and weight loss impacts.

Main Methods:

  • Literature review of studies on obesity, heart failure, and weight loss interventions.
  • Analysis of pathophysiological mechanisms linking obesity to cardiac dysfunction.
  • Examination of survival data related to obesity in heart failure patients.

Main Results:

  • Obesity leads to cardiac structural and functional changes, impacting systolic and diastolic function.
  • Weight loss interventions (lifestyle, pharmacologic, surgical) improve cardiac function and reduce HF hospitalizations.
  • The "obesity paradox" suggests potentially better survival in obese HF patients compared to normal-weight counterparts.

Conclusions:

  • Understanding the obesity-HF link is crucial for optimizing patient care.
  • Preventive strategies targeting HF in obese individuals are essential.
  • Weight loss interventions offer a viable approach to improve outcomes in obese HF patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
700
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
362
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
308
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334